ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. It is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. The Company utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines.